Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsJeffrey Topal, MD
Associate Clinical ProfessorAbout
Research
Publications
2026
360: EVALUATION OF A BROAD-SPECTRUM ANTIBIOTIC MONITORING TOOL ACROSS A LARGE ACADEMIC HOSPITAL SYSTEM
Fal V, Tucker N, McManus D, Davis M, Russo P, Moss I, Topal J, Minella E, Santos E, Michno A. 360: EVALUATION OF A BROAD-SPECTRUM ANTIBIOTIC MONITORING TOOL ACROSS A LARGE ACADEMIC HOSPITAL SYSTEM. Critical Care Medicine 2026, 54 DOI: 10.1097/01.ccm.0001183436.02296.77.Peer-Reviewed Original Research
2025
Clinical outcomes of metronidazole dosing strategies in obese patients with Bacteroides bloodstream infections
Shah S, Marini R, McManus D, Shields R, Topal J, Tate T. Clinical outcomes of metronidazole dosing strategies in obese patients with Bacteroides bloodstream infections. International Journal Of Antimicrobial Agents 2025, 67: 107701. PMID: 41455575, DOI: 10.1016/j.ijantimicag.2025.107701.Commentaries, Editorials and LettersA mixed-methods study assessing the performance of a clinical decision support tool for Clostridioides difficile testing for patients receiving laxatives
Peaper D, Rathod S, Sussman L, Azar M, Murdzek C, Roberts S, Tichy E, Topal J, Kashyap N, McManus D, Martinello R. A mixed-methods study assessing the performance of a clinical decision support tool for Clostridioides difficile testing for patients receiving laxatives. Infection Control And Hospital Epidemiology 2025, 46: 497-503. PMID: 40079209, PMCID: PMC12034449, DOI: 10.1017/ice.2025.30.Peer-Reviewed Original Research
2024
Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infections
Shah S, Adams K, Clarke L, Ludwig J, McManus D, Nguyen M, Topal J, Shields R. Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infections. International Journal Of Antimicrobial Agents 2024, 65: 107403. PMID: 39667533, DOI: 10.1016/j.ijantimicag.2024.107403.Peer-Reviewed Original ResearchImproving cefazolin administration for surgical prophylaxis in reported penicillin allergy: A retrospective study of a health system intervention
Belmont A, Son M, Hyman J, You L, Topal J, McManus D, Martinello R, Kwah J. Improving cefazolin administration for surgical prophylaxis in reported penicillin allergy: A retrospective study of a health system intervention. Journal Of Allergy And Clinical Immunology Global 2024, 4: 100377. PMID: 39830990, PMCID: PMC11742594, DOI: 10.1016/j.jacig.2024.100377.Peer-Reviewed Original ResearchClinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis
Shah S, Clarke L, Davis M, Topal J, Shields R. Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis. Journal Of Antimicrobial Chemotherapy 2024, 79: 2017-2021. PMID: 38958234, PMCID: PMC12102595, DOI: 10.1093/jac/dkae205.Peer-Reviewed Original ResearchNocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19
Marvin J, McSweeney T, Cohen E, Davis M, Belfield K, Do V, McManus D, Tirmizi S, Topal J. Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19. Transplantation 2024, 108: e150-e151. PMID: 38917242, DOI: 10.1097/tp.0000000000004974.Commentaries, Editorials and LettersClinical outcomes of baloxavir versus oseltamivir in immunocompromised patients
McManus D, Davis M, Shah S, Topal J, Azar M. Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients. Transplant Infectious Disease 2024, 26: e14249. PMID: 38319665, DOI: 10.1111/tid.14249.Peer-Reviewed Original Research